Novavax: Another Day Older And Deeper In: Novavax's Q4 2023 earnings were a miss that roiled the market. Find out why there can be no assurance that NVAX stock ...
seekingalpha.com/article/4675457-novavax-another-day-older-and-deeper-in
Paid articlePaid
Novavax Stock Sinks as Revenue Misses Estimates in ‘Transition Year’: Novavax posts a fourth-quarter loss of $1.44 a share on revenue of $291.3 million.
barrons.com/articles/novavax-earnings-stock-price-3038f394
Paid articlePaid
Novavax collapses by numbers - collect now?: Novavax Stock Plunges 25% After Quarterly Figures; high costs reduced, sales falling, future uncertain.
deraktionaer.de/artikel/pharma-biotech/novavax-bricht-nach-zahlen-ein-jetzt-einsammeln-20351621.html
Novavax Stock Soars 25%. A Vaccine Purchase Settlement Is One Reason Why.: Novavax reaches a settlement related to an advance purchase agreement with Gavi.
barrons.com/articles/novavax-stock-covid-vaccine-purchase-settlement-4bd47eb9
Paid articlePaid
Novavax settles dispute with international vaccine group Gavi: Novavax has agreed to pay back international vaccine group Gavi at least $475 million in cash or ...
reuters.com/business/healthcare-pharmaceuticals/novavax-settles-dispute-with-international-vaccine-group-gavi-2024-02-22/
Novavax to cut 12% of its global workforce: The job cuts would impact both full-time employees and contractors
straitstimes.com/business/novavax-to-cut-12-of-its-global-workforce
People with medical allergies could finally get first Covid jab – if they pay £45
inews.co.uk/news/medical-allergies-first-covid-jab-2903367
Florida loves individual rights — unless you want a COVID vaccine: The Florida surgeon general called receiving such vaccines “anti-human.”
thehill.com/opinion/healthcare/4416119-florida-loves-individual-rights-unless-you-want-a-covid-vaccine/
CDC says 3,752 people given Novavax XBB.1.5 vaccine: Bringing Taiwan to the World and the World to Taiwan
taipeitimes.com/News/taiwan/archives/2024/01/11/2003811945
CDC urges public to get XBB vaccine for fast changing COVID-19 - Focus Taiwan: Taipei, Jan. 5 (CNA) People should get at least one shot of the XBB vaccine due to ...
focustaiwan.tw/society/202401050018
New coronavirus variant JN.1 is spreading fast. Here’s what to know.: The WHO declared JN.1 a “variant of interest” as cases spread globally ...
washingtonpost.com/wellness/2023/12/20/new-covid-variant-jn1-symptoms/
Quick Glance: JN.1 Variant: Latest on Covid Developments
- The JN.1 variant may be more transmissible, but does not cause more severe Covid cases.
- Covid cases are on the rise, driven by the JN.1 variant, according to Dr. Mandy Cohen of the Centers for Disease Control and Prevention.
- JN.1 accounts for about 21% of Covid cases in the US, up from 8% just two weeks ago, according to the CDC.
- The World Health Organization has designated JN.1 as a 'variant of interest', indicating genetic changes that could enhance its spread.
Novavax's updated COVID-19 vaccine to help provide wider array of choices : SK bioscience began its domestic supply of Novavax’s updated COVID-19 vaccine ...
koreatimes.co.kr/www/tech/2023/12/779_365687.html
WHO authorizes emergency use of Novavax's updated COVID shot: Novavax's (NVAX.O) updated vaccine has been granted emergency-use authorization by the World Health ...
reuters.com/business/healthcare-pharmaceuticals/who-authorizes-emergency-use-novavaxs-updated-covid-vaccine-2023-11-28/
Quick Glance: WHO Approves Novavax's Updated COVID Vaccine
- The World Health Organization (WHO) has granted emergency use authorization for Novavax's updated vaccine for active immunization against COVID-19, approved for individuals aged 12 and older.
- The updated Novavax vaccine targets a descendant of the XBB lineage of the coronavirus that was globally predominant earlier this year.
- Novavax missed out on the COVID-19 vaccine windfall due to manufacturing issues that delayed its approval, and its original COVID shot was only authorized in the US in July 2022.
Vaccination against corona: Novavax vaccine from 11.12. - Questions & Answers: There are many coronavirus cases and deaths again. The RKI calls for vaccination ...
rp-online.de/leben/gesundheit/impfung-gegen-corona-novavax-impfstoff-ab-1112-fragen-und-antworten_aid-102768239
COVID-19 Vaccines for Kids: What To Know and Why It’s Important: For added safety, kids 6 months old and up are recommended to get the most updated COVID-19 ...
health.clevelandclinic.org/covid-vaccine-for-kids
Health Canada authorizes Novavax's updated COVID shot for Omicron: Novavax (NVAX.O) said on Tuesday that Health Canada had authorized its updated COVID-19 ...
reuters.com/world/americas/health-canada-authorizes-novavaxs-updated-covid-shot-omicron-2023-12-05/
Data suggests that people report fewer side effects after Novavax's Covid vaccine.
Because of that, some people have held out on their booster until they ... Show more
Novavax COVID-19 vaccine no longer available in Singapore from 2024; existing stock to expire at year-end
channelnewsasia.com/singapore/moh-novavax-nuvaxovoid-covid-19-vaccine-no-longer-available-expire-december-31-3951396
Data suggests that people report fewer side effects after Novavax's Covid vaccine.
Because of that, some people have held out on their booster until they ... Show more
Novavax: Do Not Expect A Turnaround In 2024: Novavax faces major challenges in 2024, including a significant Gavi dispute and going concern issues ...
seekingalpha.com/article/4659859-novavax-do-not-expect-turnaround-2024-rating-downgrade
Paid articlePaid
Understanding JN.1: The Latest Omicron Subvariant Adding to COVID-19 Worries: JN.1, a new subvariant of the Omicron strain, has driven up COVID-19 infections and ...
techtimes.com/articles/299917/20231220/understanding-jn-1-latest-omicron-subvariant-adding-covid-19-worries.htm
Vaccine maker Novavax tops revenue estimates, eyes more cost cuts: COVID-19 vaccine maker Novavax (NVAX.O) on Thursday beat market estimates for quarterly ...
reuters.com/business/healthcare-pharmaceuticals/covid-vaccine-maker-novavax-reports-better-than-expected-revenue-2023-11-09/
Over 15 million Americans got updated COVID vaccines so far: Over 15 million people in the United States, around 4.5% of the population, had received the updated ...
reuters.com/world/us/over-15-mln-americans-got-updated-covid-vaccines-so-far-2023-11-01/
Is the Novavax COVID Vaccine Better than mRNA Vaccines? What We Know So Far: Scientific American is the essential guide to the most awe-inspiring advances in ...
scientificamerican.com/article/is-the-novavax-covid-vaccine-better-than-mrna-vaccines-what-we-know-so-far/
Quick Glance: Novavax optimistic about updated COVID vaccine availability in the US
- Novavax is encouraged by the broad availability of its updated COVID-19 vaccine in the US.
- Shares of vaccine maker Novavax and rival Moderna were down 6% to 7% after Pfizer expressed concerns about lower-than-expected sales of its COVID-19 vaccine.
- Novavax continues to work closely with the European Medicines Agency (EMA) as the regulator delays a decision on approval for the company's variant-tailored COVID-19 shot.
Order now possible: Adapted COVID-19 vaccine from Novavax: Berlin - Doctors' practices can now use the US manufacturer's protein-based COVID-19 vaccine adapted ...
aerzteblatt.de/nachrichten/147755/Bestellung-jetzt-moeglich-Angepasster-COVID-19-Impfstoff-von-Novavax
Is Novavax, the latecomer COVID-19 vaccine, worth the wait?: The shot, which is based on proteins rather than mRNA, appears to be as effective as the COVID ...
sfchronicle.com/health/article/novavax-covid-vaccine-18510154.php
EU delays approval of Novavax's revised COVID vaccine - FT: European Union (EU) regulators have delayed a decision to give approval for Novavax's (NVAX ...
reuters.com/business/healthcare-pharmaceuticals/eu-delays-approval-novavaxs-revised-covid-vaccine-ft-2023-10-15/
Is Novavax, the latecomer COVID vaccine, worth the wait?: Research suggests that the Novavax COVID vaccine is about as safe and effective as the mRNA shots.
bostonherald.com/2023/11/22/is-novavax-the-latecomer-covid-vaccine-worth-the-wait/
Updated Novavax COVID-19 vaccine shipped to distributors, to be available this week
reuters.com/business/healthcare-pharmaceuticals/updated-novavax-covid-19-vaccine-shipped-distributors-be-available-this-week-2023-10-09/
Another option for COVID-19 vaccinations approved: U.S. regulators on Tuesday authorized another option for fall COVID-19 vaccination: updated shots made by ...
ajc.com/news/health-news/another-option-for-covid-19-vaccinations-approved/APOH5TTLFRFQDH4XYL6DVDFAO4/
Quick Glance: US FDA approves updated Novavax COVID vaccine
- The updated COVID-19 vaccine from Novavax has been authorized by the US Food and Drug Administration for emergency use in individuals aged 12 years and older.
- The company's shares increased by more than 11%.
- Novavax is relying on the commercial sale of its updated vaccine to ensure its economic survival.
- The CDC's Advisory Committee on Immunization Practices (ACIP) will not schedule another meeting to discuss the Novavax vaccine.
Vaccinating to stem the fall Covid wave.: The online edition of the Austrian daily newspaper Die Presse.
diepresse.com/17742005/impfen-zur-eindaemmung-der-herbst-covid-welle
Updated Novavax COVID vaccine to arrive in Taiwan in December: CDC - Focus Taiwan
focustaiwan.tw/society/202311080017
COVID-19: Third adapted vaccine approved.: Brussels - The European Commission has approved another COVID-19 vaccine, Nuvaxovid, developed by Novavax and adapted ...
aerzteblatt.de/nachrichten/147025/COVID-19-Dritter-angepasster-Impfstoff-zugelassen
Quick Glance: COVID-19: New Adapted Vaccine Approved
- The European Commission has approved the Nuvaxovid vaccine developed by Novavax.
- It is the first protein-based adapted vaccine approved for the autumn and winter season.
- Vaccinations continue to be our most effective tool against COVID-19.
- The European Medicines Agency (EMA) thoroughly assessed Nuvaxovid.
Novavax’s updated protein-based COVID vaccine finally authorized by FDA: The shot already has CDC signoff and is available to everyone 12 and up.
arstechnica.com/health/2023/10/novavaxs-updated-protein-based-covid-vaccine-finally-authorized-by-fda/
Europe to decide on Novavax's COVID vaccine in October: The European Medicines Agency (EMA) expects to decide on the use of Novavax's (NVAX ...
reuters.com/business/healthcare-pharmaceuticals/europe-expects-decide-novavaxs-covid-vaccine-october-2023-09-21/
Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting Demand
forbesafrica.com/current-affairs/2023/10/17/vaccine-stocks-including-pfizer-moderna-biontech-and-novavax-slide-amid-plummeting-demand/
Quick Glance: BioNTech stock plummets – uncovering the reasons
- BioNTech stock is currently down almost 10%.
- BioNTech is now examining its business.
- Weak demand for COVID-19 vaccines hampers BioNTech's business.
Does It Matter Which COVID-19 Booster Shot You Get?: With a new booster available, it’s time to look at whether switching up your shots makes a difference in ...
time.com/6317294/which-covid-19-booster-shot-to-get/
Over 7 Million Americans Have So Far Received Updated Covid Vaccines, Here're Few Facts About Immunity Plans
indiatimes.com/trending/human-interest/updated-covid-vaccines-for-over-7-million-americans-617570.html
Quick Glance: Over 7 Million People Receive Updated COVID Vaccine
- FDA approved Pfizer and Moderna shots on Sept. 11, and distribution began on Sept. 12.
- 14 million vaccines have been shipped to pharmacies and other locations.
- The HHS numbers are likely an undercount due to the commercialization of the vaccine and lack of specific breakdowns.
- The latest vaccine effort is on par with the 2022 rollout of the bivalent booster shot.
Novavax touts non-mRNA COVID vaccine, future of domestic production remains uncertain
torontosun.com/news/national/novavax-touts-non-mrna-covid-vaccine-future-of-domestic-production-remains-uncertain
WHO recommends Oxford-Serum Institute malaria vaccine for global rollout: India malaria vaccine: India roll-out timelines not known immediately
business-standard.com/companies/news/oxford-serum-institute-of-india-malaria-vaccine-gets-who-approval-123100201024_1.html
New corona preparations: vaccinations starting today - with adapted omicron vaccines
spiegel.de/panorama/ab-heute-wird-geimpft-mit-angepassten-omikron-impfstoffen-a-83c3515d-475b-448c-b0a2-5548579c1752
Quick Glance: Start of Corona Vaccination Season with Adapted Omicron Vaccines
- Recommended vaccination for vulnerable groups: Biontech, Moderna, and Novavax as adapted vaccines
- Experts predict strain on healthcare system in the fall
- Distribution of adapted Biontech vaccine begins today
- Newly approved adapted vaccines from Moderna and Novavax
Pfizer forecasts 24% COVID vaccination rate in US this year: Pfizer (PFE.N) expects 24% vaccination rate for COVID-19 shots in the United States this year ...
reuters.com/business/healthcare-pharmaceuticals/pfizer-expects-24-uptake-covid-vaccines-us-cfo-2023-09-18/
When can I get the new COVID vaccine? Fresh shots OK'd by FDA to hit pharmacies: There's still some debate within the medical community about whether everyone ...
usatoday.com/story/news/health/2023/09/11/new-covid-booster-shots-approved/70825512007/
CDC Endorses New COVID-19 Vaccines, Allowing Shots to Begin This Week: The updated shots from Pfizer and Moderna will be available this week ...
usnews.com/news/health-news/articles/2023-09-12/cdc-vaccine-committee-endorses-new-covid-19-shots
Quick Glance: CDC director emphasizes importance of updated COVID booster shot amid increasing cases
- The CDC recommended updated COVID booster shots for Americans aged 6 months and older due to rising cases and hospitalizations across the country.
- In an interview with ABC News Live on Tuesday night, CDC Director Mandy Cohen stressed the importance of getting the updated shot and addressed safety concerns, stating that the shots have been studied 'more than any vaccine in history.'
- The CDC recommends that everyone should get the updated COVID vaccine, and it will be available in doctor's offices and pharmacies across the country in the coming days.
- The CDC director expressed concern that fewer than half of adults over 65 and only 1 in 5 Americans received the booster shot last fall.
Corona vaccination: booster with matched omicron vaccine possible.: Corona vaccination with an adapted vaccine for current Omikron variants is recommended for ...
stern.de/gesundheit/corona-impfung--auffrischung-mit-angepassten-omikron-impfungen-moeglich-33835190.html
Novavax's updated COVID shot shows immune response against subvariant Eris: Novavax Inc (NVAX.O) said on Tuesday its updated protein-based COVID-19 vaccine ...
reuters.com/business/healthcare-pharmaceuticals/novavaxs-updated-covid-vaccine-shows-response-against-eris-variant-2023-08-22/
Quick Glance: Novavax's updated COVID vaccine shows immune response to subvariant Eris
- Novavax's updated protein-based COVID-19 vaccine demonstrates immune response to emerging forms of coronavirus like the 'Eris' subvariant in animal studies.
- COVID infections and hospitalizations are increasing in the United States, Europe, and Asia, with recent cases attributed to the EG.5 subvariant - nicknamed 'Eris' - a descendant of the Omicron lineage that first emerged in November 2021.
- For the fall season, COVID vaccine makers are preparing with updated shots targeting the Omicron subvariant XBB.1.5.
- Both Moderna and Pfizer have stated that their vaccines also show promise against Eris.
oronavirus: manufacturers to begin shipping adjusted covid vaccines in September: Corona vaccines adapted to the XBB.1.5 variant are to come onto the market for ...
zeit.de/wissen/2023-08/coronavirus-impfstoffe-xbb-1-5-infektionen-anstieg
Quick Glance: Adapted BioNTech Vaccines for Covid-19 Variants Ready for Delivery
- New vaccines from BioNTech are set to launch in September, adapted to the prevailing Covid-19 variants.
- Vaccines for the new Covid-19 variants are nearing delivery.
- BioNTech and Pfizer have adapted their vaccine to the XBB.1.5 Omicron variant.
- Doctors can now administer them more easily.
Pfizer's updated COVID shot effective against 'Eris' variant in mice study: Pfizer Inc (PFE.N) said on Thursday its updated COVID-19 shot, which is being tested ...
reuters.com/business/healthcare-pharmaceuticals/pfizers-updated-covid-shot-effective-against-eris-variant-mice-study-2023-08-17/
Quick Glance: Pfizer's Updated COVID Shot Effective Against 'Eris' Variant in Mice Study
- Pfizer reports neutralizing activity of its updated COVID-19 shot against the 'Eris' subvariant in a study conducted on mice.
- Pfizer, along with its German partner BioNTech SE, and other COVID-19 vaccine makers like Moderna and Novavax, has developed versions of their shots targeting the XBB.1.5 subvariant.
- The EG.5 subvariant, nicknamed 'Eris', is similar to the XBB.1.5 subvariant and is a sub-lineage of the still-dominant Omicron variant.
- According to the latest government data, EG.5 accounted for over 17% of COVID-19 cases in the United States.
Moderna says new Covid vaccine was effective against Eris variant in early trial
cnbc.com/2023/08/17/moderna-covid-vaccine-effective-against-eris-fornax-variants.html
Quick Glance: Moderna's Updated COVID Vaccine Effective Against 'Eris' Variant in Humans
- Moderna announces initial study data showing effectiveness of updated COVID-19 vaccine against 'Eris' and 'Fornax' subvariants in humans.
- The updated vaccine is expected to be available in the coming weeks for the fall vaccination season, pending approval from health regulators in the US, Europe, and elsewhere.
- Moderna, along with Novavax, Pfizer, and BioNTech, has developed versions of their vaccines targeting the XBB.1.5 subvariant.
- Pfizer reports neutralizing activity against the Eris subvariant in a mouse study for its updated COVID-19 vaccine co-developed with BioNTech.
Moderna says updated Covid vaccine was effective against highly mutated BA.2.86 variant in trial
cnbc.com/2023/09/06/moderna-says-new-covid-vaccine-effective-against-bapoint2point86-variant.html
Quick Glance: Moderna and Pfizer: Strong Response to New COVID Variant
- Moderna's vaccine shows strong response to BA.2.86 variant in clinical trials
- Pfizer's vaccine shows strong antibody response to BA.2.86 in mouse study
- Moderna and Pfizer vaccines are based on mRNA technology
- European authorities have approved Pfizer/BioNTech vaccine, Moderna vaccine pending
COVID-19 hospitalizations in the US are on the rise again, but not like before: COVID-19 hospital admissions are inching upward in the United States since early ...
apnews.com/article/covid-cases-hospitalizations-increasing-9a831de37210c53c1ee48a30ad2ee611
COVID-19 hospitalizations in the US are on the rise again, but not like before: COVID-19 hospital admissions have been inching upward in the U.S ...
seattletimes.com/seattle-news/health/covid-19-hospitalizations-in-the-us-are-on-the-rise-again-but-not-like-before/
BioNTech: Corona vaccination season starts - more news expected today: The corona vaccination season begins with the BioNTech vaccine adapted to virus variants ...
deraktionaer.de/artikel/aktien/biontech-corona-impfsaison-startet-heute-weitere-news-erwartet-20339547.html
Novavax to sell 7% stake to South Korea's SK Bioscience: SK Bioscience (302440.KS) is taking a roughly 7% stake in Novavax (NVAX.O) in lieu of some payment owed ...
reuters.com/business/healthcare-pharmaceuticals/novavax-posts-unexpected-q2-profit-earlier-covid-revenue-2023-08-08/
BioNTech and Moderna succeed, Novovax slips - the backgrounds: The FDA has approved the adapted Covid-19 vaccines from BioNTech/Pfizer and Moderna ...
deraktionaer.de/artikel/pharma-biotech/biontech-und-moderna-mit-erfolg-novovax-rutscht-ab-die-hintergruende--20339256.html
Novavax to sell 7% stake to South Korea's SK Bioscience: SK Bioscience (302440.KS) is taking a roughly 7% stake in Novavax (NVAX.O) in lieu of some payment owed ...
reuters.com/business/healthcare-pharmaceuticals/novavax-posts-unexpected-q2-profit-earlier-covid-revenue-2023-08-08/
Covid vaccine stocks jump as new variants emerge ahead of fall shot rollout: Novavax, Moderna, Pfizer and its partner BioNTech are slated to roll out new shots ...
cnbc.com/2023/08/21/covid-vaccine-stocks-jump-as-new-variants-emerge.html
Pfizer, Moderna Try To Squeeze Blood From A Stone. Why It Likely Won't Work.: The biggest names in Covid are updating their vaccines for a fall campaign ...
investors.com/news/technology/pfizer-stock-why-covid-boosters-likely-will-not-be-its-saving-grace/
Quick Glance: Moderna expects up to $4 billion in sales by 2023 from private market for COVID vaccines
- Previous expectation of $5 billion sales from government contracts revised.
- The government-backed market for COVID vaccines is shrinking, with Moderna and Pfizer (PFE.N) reporting a significant decline in second-quarter sales.
- Moderna anticipates a demand of 50 to 100 million doses of the vaccine in the US during the fall season, based on the size of the flu market estimated at 150 million doses annually.
- Moderna and Pfizer have yet to announce the final price for their vaccines in the private market, but expect it to be substantially higher than the price charged to governments during the peak of the pandemic.
The Food and Drug Administration (FDA) has approved the first vaccine meant to prevent infections in infants, with the new drug designed to be administered to ... Show more
COVID-19: New vaccine booster also protects against current omicron variants: Cambridge/Massachusetts - The new corona vaccine, which is to be introduced in ...
aerzteblatt.de/nachrichten/145622/COVID-19-Neuer-Impfstoffbooster-schuetzt-auch-vor-aktuellen-Omikron-Varianten
As the new Eris Covid variant spreads across the world, here’s what we know so far
cnbc.com/2023/08/15/covid-eris-new-variant-spreads-across-world-heres-what-we-know-so-far.html
Novavax to receive $350 million from Canada for unused COVID shots: Novavax Inc (NVAX.O) said on Friday Canada will pay $349.6 million to settle the forfeiting ...
reuters.com/business/healthcare-pharmaceuticals/novavax-receive-350-mln-canada-unused-covid-shots-2023-07-07/
Quick Glance: Novavax to Receive $350 Million from Canada for Unused COVID Vaccines
- Canada will pay $349.6 million to acquire undelivered COVID-19 vaccine doses from Novavax.
- Novavax has reached an agreement with the country's public works and government services department to amend the advance purchase contract.
- The number of vaccine doses due for delivery has been reduced and the delivery schedule has been revised.
- The payment will be made in two equal installments in 2023 and the value of the contract remains unchanged.
COVID shots should target XBB variants in 2023-24 campaign, US FDA staff say: COVID-19 vaccines being developed and manufactured for the 2023-2024 campaign ...
reuters.com/business/healthcare-pharmaceuticals/updated-covid-vaccines-need-target-xbb-strains-us-fda-staff-2023-06-12/
Novavax exec says its new COVID shot should work against variants on the rise: Novavax Inc's (NVAX.O) head of research and development on Monday said an updated ...
reuters.com/business/healthcare-pharmaceuticals/novavax-exec-says-its-new-covid-shot-should-work-against-variants-rise-2023-06-05/
Moderna files for FDA approval of updated Covid vaccine for fall : Moderna said the submission is based on the FDA's recommendation that vaccine makers update ...
cnbc.com/2023/06/22/moderna-files-for-fda-approval-of-updated-covid-vaccine-for-fall.html
Quick Glance: Moderna seeks FDA authorization for updated COVID vaccine
- Moderna has submitted an application to the US Food and Drug Administration (FDA) seeking authorization for its updated COVID-19 vaccine targeting the XBB.1.5 subvariant.
- In accordance with FDA recommendations, Moderna is developing a monovalent vaccine to target XBB.1.5.
- Preliminary clinical data from Moderna demonstrates a strong immune response from the XBB.1.5 monovalent vaccine against XBB-descendent lineage viruses.
- Pending authorization, the updated vaccine will be available in time for the fall vaccination season.
Pfizer, Moderna and Novavax gear up for fall Covid vaccine rollout with an important head start
cnbc.com/2023/06/20/covid-vaccines-pfizer-moderna-and-novavax-gear-up-for-fall-rollout.html
Closing bell: US stocks rally, tech stocks stem losses, Novavax and auto stocks up
deraktionaer.de/artikel/maerkte-forex-zinsen/schlussglocke-us-boersen-ziehen-an-techaktien-daemmen-verluste-ein-novavax-und-autowerte-obenauf--20335403.html
Big hit at Novavax: payment of millions catapults the share upwards: Vaccine manufacturer Novavax has received a three-digit million payment from Canada for ...
deraktionaer.de/artikel/aktien/paukenschlag-bei-novavax-millionenzahlung-katapultiert-aktie-nach-oben-20335401.html
Covid vaccine maker Novavax sees a pathway to survival – but it won’t be easy : Cash-strapped Covid vaccine Novavax still faces a nunber of challenges ...
cnbc.com/2023/06/14/why-novavax-path-to-survival-wont-be-easy-.html
FDA advisers back updated COVID-19 vaccine targeting dominant variant: COVID-19 vaccine makers Pfizer-BioNTech, Moderna, and Novavax are already developing ...
rappler.com/science/life-health/fda-advisers-back-updated-covid-19-vaccine-targeting-xbb-variant/
Novavax Partners With Gates Foundation Offshoot In Efforts To Develop Malaria And TB Shots
forbes.com/sites/roberthart/2023/06/05/novavax-partners-with-gates-foundation-offshoot-in-efforts-to-develop-malaria-and-tb-shots/
Novavax Partners With Gates Foundation Offshoot In Efforts To Develop Malaria And TB Shots
forbes.com/sites/roberthart/2023/06/05/novavax-partners-with-gates-foundation-offshoot-in-efforts-to-develop-malaria-and-tb-shots/
Novavax Covid-19 vaccine approved for those aged 12 to 17, appointment bookings open on May 15
straitstimes.com/singapore/novavax-covid-19-vaccine-approved-for-those-aged-12-to-17-appointment-bookings-open-on-may-15
WHO recommends new Covid-19 shots should target only XBB variants: Covid-19 vaccine makers are already developing versions of their vaccines targeting XBB.1.5 ...
straitstimes.com/world/europe/who-recommends-new-covid-19-shots-should-target-only-xbb-variants
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics